Long-term healthcare use and costs in patients with stable coronary artery disease: A population-based cohort using linked health records (CALIBER)

European Heart Journal - Quality of Care and Clinical Outcomes

Volumn 2, Issue 2, 2016, Pages 125-140

  Walker, Simon ^a   Asaria, Miqdad ^a   Manca, Andrea ^a   Palmer, Stephen ^a   Gale, Chris P ^b   Shah, Anoop Dinesh ^c   Abrams, Keith R ^d   Crowther, Michael ^e   Timmis, Adam ^f   Hemingway, Harry ^c   Sculpher, Mark ^a  

^a UNIVERSITY OF YORK   (United Kingdom)

^b UNIVERSITY OF LEEDS   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d Centre for Biostatistics and Genetic Epidemiology   (United Kingdom)

^e UNIVERSITY OF LEICESTER   (United Kingdom)

^f BARTS HEALTH NHS TRUST   (United Kingdom)

Author keywords

Costs; Electronic health records; Resource use; Stable coronary artery disease

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CARDIOVASCULAR AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

AGED; ARTICLE; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CARDIOVASCULAR RISK; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; DRUG COST; ENGLAND; FEMALE; HEALTH CARE COST; HEALTH CARE UTILIZATION; HEART FAILURE; HEART INFARCTION; HOSPITALIZATION; HUMAN; LIFE EXPECTANCY; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; PREDICTION; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; SECONDARY HEALTH CARE; SEX DIFFERENCE; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; STABLE ANGINA PECTORIS; UNSTABLE ANGINA PECTORIS;

EID: 85020528205     PISSN: 20585225     EISSN: 20581742     Source Type: Journal    
DOI: 10.1093/ehjqcco/qcw003     Document Type: Article

References (25)

1. Gale CP, Cattle BA, Woolston A, Baxter PD, West TH, Simms AD, Blaxill J, Greenwood DC, Fox KAA, West RM. Resolving inequalities in care? Reduced mortality in the elderly after acute coronary syndromes. The Myocardial Ischaemia National Audit Project 2003–2010. Eur Heart J 2012;33:630–639.
2. Hall M, Alabas O, Dondon T, Jernberg T, Gale C. Use of relative survival to evaluate non ST-elevation myocardial infarction quality of care and clinical outcomes. EHJQCCO.
3. Gale CP, Allan V, Cattle BA, Hall AS, West RM, Timmis A, Gray HH, Deanfield J, Fox KAA, Feltbower R. Trends in hospital treatments, including revascularisation, following acute myocardial infarction, 2003–2010: a multilevel and relative survival analysis for the National Institute for Cardiovascular Outcomes Research (NICOR). Heart 2014;100:582–589.
4. Alabas OA, Allan V, McLenachan JM, Feltbower R, Gale CP. Age-dependent improvements in survival after hospitalisation with acute myocardial infarction: an analysis of the Myocardial Ischemia National Audit Project (MINAP). Age Ageing 2014;43:779–785.
5. Task Force Members, Montalescot G, Sechtem U, Achenbach S, Andreotti F, Arden C, Budaj A, Bugiardini R, Crea F, Cuisset T, Di Mario C, Ferreira JR, Gersh BJ, Gitt AK, Hulot JS, Marx N, Opie LH, Pfisterer M, Prescott E, Ruschitzka F, Sabaté M, Senior R, Taggart DP, van der Wall EE, Vrints CJ; ESC Committee for Practice Guidelines, Zamorano JL, Achenbach S, Baumgartner H, Bax JJ, Bueno H, Dean V, Deaton C, Erol C, Fagard R, Ferrari R, Hasdai D, Hoes AW, Kirchhof P, Knuuti J, Kolh P, Lancellotti P, Linhart A, Nihoyannopoulos P, Piepoli MF, Ponikowski P, Sirnes PA, Tamargo JL, Tendera M, Torbicki A, Wijns W, Windecker S; Document Reviewers, Knuuti J, Valgimigli M, Bueno H, Claeys MJ, Donner-Banzhoff N, Erol C, Frank H, Funck-Brentano C, Gaemperli O, Gonzalez-Juanatey JR, Hamilos M, Hasdai D, Husted S, James SK, Kervinen K, Kolh P, Kristensen SD, Lancellotti P, Maggioni AP, Piepoli MF, Pries AR, Romeo F, Rydén L, Simoons ML, Sirnes PA, Steg PG, Timmis A, Wijns W, Windecker S, Yildirir A, Zamorano JL. 2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology. Eur Heart J 2013;34:2949–3003.
6. Fihn SD, Gardin JM, Abrams J, Berra K, Blankenship JC, Dallas AP, Douglas PS, Foody JM, Gerber TC, Hinderliter AL, King SB, Kligfield PD, Krumholz HM, Kwong RYK, Lim MJ, Linderbaum A, Mack MJ, Munger MA, Prager RL, Sabik JF, Shaw LJ, Sikkema JD, Smith CR, Smith SC, Spertus JA, Williams SV. 2012 ACCF/ AHA/ACP/AATS/PCNA/SCAI/STS guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol 2012;60:e44–e164.
7. Kolandaivelu K, Leiden BB, O'Gara PT, Bhatt DL. Non-adherence to cardiovascular medications. Eur Heart J 2014;35:3267–3276.
8. Rapsomaniki E, Shah A, Perel P, Denaxas S, George J, Nicholas O, Udumyan R, Feder GS, Hingorani AD, Timmis A, Smeeth L, Hemingway H. Prognostic models for stable coronary artery disease based on electronic health record cohort of 102 023 patients. Eur Heart J 2014;35:844–852.
9. Mark DB, Naylor CD, Hlatky MA, Califf RM, Topol EJ, Granger CB, Knight JD, Nelson CL, Lee KL, Clapp-Channing NE, Sutherland W, Pilote L, Armstrong PW. Use of medical resources and quality of life after acute myocardial infarction in Canada and the United States. N Engl J Med 1994;331:1130–1135.
10. Reed SD, Radeva JI, Weinfurt KP, McMurray JJ, Pfeffer MA, Velazquez EJ, Allsbrook JS, Masselink LE, Sellers MA, Califf RM, Schulman KA, Valiant I. Resource use, costs, and quality of life among patients in the multinational Valsartan in Acute Myocardial Infarction Trial (VALIANT). Am Heart J 2005;150: 323–329.
11. Briggs A, Mihaylova B, Sculpher M, Hall A, Wolstenholme J, Simoons M, Deckers J, Ferrari R, Remme WJ, Bertrand M, Fox K. Cost effectiveness of perindopril in reducing cardiovascular events in patients with stable coronary artery disease using data from the EUROPA study. Heart 2007;93:1081–1086.
12. Gallagher A, Puri S, van Staa T. Linkage of the general practice research database (GPRD) with other data sources. Pharmacoepidemiol Drug Saf 2011;20: S230–S367.
13. Mathur R, Bhaskaran K, Chaturvedi N, Leon DA, van Staa T, Grundy E, Smeeth L. Completeness and usability of ethnicity data in UK-based primary care and hospital databases. J Public Health (Oxf) 2014;36:684–692.
14. Herrett E, Shah AD, Boggon R, Denaxas S, Smeeth L, van Staa T, Timmis A, Hemingway H. Completeness and diagnostic validity of recording acute myocardial infarction events in primary care, hospital care, disease registry, and national mortality records: cohort study. BMJ 2013;346:f2350.
15. Denaxas SC, George J, Herrett E, Shah AD, Kalra D, Hingorani AD, Kivimaki M, Timmis AD, Smeeth L, Hemingway H. Data resource profile: cardiovascular disease research using linked bespoke studies and electronic health records (CALIBER). Int J Epidemiol 2012;41:1625 – 1638.
16. Curtis L. Unit Costs of Health and Social Care 2012. http://www.pssru.ac.uk/project-pages/unit-costs/2012/.
17. Department of Health. NHS reference costs: financial year 2011 to 2012. https://www.gov.uk/government/publications/nhs-reference-costs-financial-year-2011to-2012.
18. Health and Social Care Information Centre. Prescription cost analysis - England, 2012. http://www.hscic.gov.uk/catalogue/PUB10610.
19. White IR, Royston P, Wood AM. Multiple imputation using chained equations: issues and guidance for practice. Stat Med 2011;30:377–399.
20. Asaria M, Walker S, Palmer S, Gale CP, Shah AD, Abrams K, Crowther M, Manca A, Timmis A, Hemingway H, Sculpher M. Using electronic health records to predict costs and outcomes in chronic disease using the example of stable coronary artery disease. Heart (in press).
21. NICE. Guide to the methods of technology appraisal. Regulation 2008;26:76.
22. Hippisley-Cox J, Vinogradova Y. Trends in Consultation Rates in General Practice 1995 to 2008: Analysis of the QRESEARCH Database. Nottingham, UK: QRESEARCH; 2009. p1 – 23. http://scholar.google.com/scholar?hl=en&btnG=Search&q=intitle:Trends+in+Consultation+Rates+in+General+Practice+1995+to+2008+:+Analysis+ of+the+QResearch+w#0 (24 November 2014).
23. Kasteridis P, Street A, Dolman M, Gallier L, Hudson K, Martin J, Wyer I. The importance of multimorbidity in explaining utilisation and costs across health and social care settings: evidence from South Somersets Symphony Project. CHE Res Pap 96. 2014. http://ideas.repec.org/p/chy/respap/96cherp.html (24 November 2014).
24. Vogeli C, Shields AE, Lee TA, Gibson TB, Marder WD, Weiss KB, Blumenthal D. Multiple chronic conditions: prevalence, health consequences, and implications for quality, care management, and costs. J Gen Intern Med 2007;22(Suppl 3): 391–395.
25. Luengo-Fernandez R, Gray AM, Rothwell PM, Oxford Vascular S. A population-based study of hospital care costs during 5 years after transient ischemic attack and stroke. Stroke 2012;43:3343–3351.